Clinical significance of hepatitis B surface antigen mutants

World Journal of Hepatology

Volumn 7, Issue 27, 2015, Pages 2729-2739

  Coppola, Nicola ^a   Onorato, Lorenzo ^a   Minichini, Carmine ^a   Di Caprio, Giovanni ^a   Starace, Mario ^a   Sagnelli, Caterina ^a   Sagnelli, Evangelista ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Hepatitis B surface antigen mutants; Hepatitis B virus infection; Immune escape hepatocellular carcinoma; Vaccine escape

Indexed keywords

EID: 84949553989     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i27.2729     Document Type: Review

References (110)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34 Suppl 1: S1-S3 [PMID: 16461208 DOI: 10.1016/S1386-6532(05)00384-7]
2. Sagnelli E, Stroffolini T, Mele A, Imparato M, Sagnelli C, Coppola N, Almasio PL. Impact of comorbidities on the severity of chronic hepatitis B at presentation. World J Gastroenterol 2012; 18: 1616-1621 [PMID: 22529690 DOI: 10.3748/wjg.v18.i14.1616]
3. Sagnelli E, Stroffolini T, Mele A, Imparato M, Almasio PL. Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. Clin Infect Dis 2008; 46: 110-113 [PMID: 18171224 DOI: 10.1086/524074]
4. Coppola N, Corvino AR, De Pascalis S, Signoriello G, Di Fiore E, Nienhaus A, Sagnelli E, Lamberti M. The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy. BMC Infect Dis 2015; 15: 149 [PMID: 25884719 DOI: 10.1186/s12879-015-0874-3]
5. Borgia G, Gentile I. Treating chronic hepatitis B: today and tomorrow. Curr Med Chem 2006; 13: 2839-2855 [PMID: 17073632 DOI: 10.2174/092986706778521995]
6. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol 2009; 15: 5761-5769 [PMID: 19998495]
7. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002; 83: 2059-2073 [PMID: 12124470]
8. Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 2008; 82: 5657-5663 [PMID: 18353958 DOI: 10.1128/jvi.02556-07]
9. Olinger CM, Jutavijittum P, Hübschen JM, Yousukh A, Samountry B, Thammavong T, Toriyama K, Muller CP. Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis 2008; 14: 1777-1780 [PMID: 18976569 DOI: 10.3201/eid1411.080437]
10. Yu H, Yuan Q, Ge SX, Wang HY, Zhang YL, Chen QR, Zhang J, Chen PJ, Xia NS. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I". PLoS One 2010; 5: e9297 [PMID: 20174575 DOI: 10.1371/journal.pone.0009297]
11. Zehender G, Ebranati E, Gabanelli E, Sorrentino C, Lo Presti A, Tanzi E, Ciccozzi M, Galli M. Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter? World J Gastroenterol 2014; 20: 7622-7634 [PMID: 24976700 DOI: 10.3748/wjg.v20.i24.7622]
12. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, Nakayoshi T, Wakuta M, Miyakawa Y, Mizokami M. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009; 83: 10538-10547 [PMID: 19640977 DOI: 10.1128/jvi.00462-09]
13. Sagnelli E, Sagnelli C, Pisaturo M, Macera M, Coppola N. Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy. World J Gastroenterol 2014; 20: 7635-7643 [PMID: 24976701 DOI: 10.3748/wjg.v20.i24.7635]
14. Ganem D, Schneider R. Hepadnaviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott-Raven, 2001: 2923-2970
15. Sagnelli C, Ciccozzi M, Pisaturo M, Lo Presti A, Cella E, Coppola N, Sagnelli E. The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. New Microbiol 2015; 38: 137-147 [PMID: 25915056]
16. Coppola N, Tonziello G, Colombatto P, Pisaturo M, Messina V, Moriconi F, Alessio L, Sagnelli C, Cavallone D, Brunetto M, Sagnelli E. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B. J Infect 2013; 67: 322-328 [PMID: 23796869]
17. Coppola N, Sagnelli C, Pisaturo M, Minichini C, Messina V, Alessio L, Starace M, Signoriello G, Gentile I, Filippini P, Sagnelli E. Clinical and virological characteristics associated with severe acute hepatitis B. Clin Microbiol Infect 2014; 20: O991-O997 [PMID: 24930916 DOI: 10.1111/1469-0691.12720]
18. Harrison T. Desk Encyclopedia of General Virology. Boston: Academic Press, 2009: 455
19. Howard CR. The biology of hepadnaviruses. J Gen Virol 1986; 67(Pt 7): 1215-1235 [PMID: 3014045 DOI: 10.1099/0022-1317-67-7-1215]
20. Schaefer S. Hepatitis B virus genotypes in Europe. Hepatol Res 2007; 37: S20-S26 [PMID: 17627630 DOI: 10.1111/j.1872-034X.2007.00099.x]
21. He B, Fan Q, Yang F, Hu T, Qiu W, Feng Y, Li Z, Li Y, Zhang F, Guo H, Zou X, Tu C. Hepatitis virus in long-fingered bats, Myanmar. Emerg Infect Dis 2013; 19: 638-640 [PMID: 23631923 DOI: 10.3201/eid1904.121655]
22. Coppola N, Loquercio G, Tonziello G, Azzaro R, Pisaturo M, Di Costanzo G, Starace M, Pasquale G, Cacciapuoti C, Petruzziello A. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. J Clin Virol 2013; 58: 315-317 [PMID: 23856167 DOI: 10.1016/j.jcv.2013.06.020]
23. Mirabelli C, Surdo M, Van Hemert F, Lian Z, Salpini R, Cento V, Cortese MF, Aragri M, Pollicita M, Alteri C, Bertoli A, Berkhout B, Micheli V, Gubertini G, Santoro MM, Romano S, Visca M, Bernassola M, Longo R, De Sanctis GM, Trimoulet P, Fleury H, Marino N, Mazzotta F, Cappiello G, Spanò A, Sarrecchia C, Zhang JM, Andreoni M, Angelico M, Verheyen J, Perno CF, Svicher V. Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection. J Infect 2015; 70: 288-298 [PMID: 25452041 DOI: 10.1016/j.jinf.2014.10.015]
24. Martin CM, Welge JA, Rouster SD, Shata MT, Sherman KE, Blackard JT. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro. J Viral Hepat 2012; 19: 716-723 [PMID: 22967103 DOI: 10.1111/j.1365-2893.2012.01595.x]
25. Weinberger KM, Bauer T, Böhm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81: 1165-1174 [PMID: 10769057]
26. Zheng X, Weinberger KM, Gehrke R, Isogawa M, Hilken G, Kemper T, Xu Y, Yang D, Jilg W, Roggendorf M, Lu M. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 2004; 329: 454-464 [PMID: 15518823 DOI: 10.1016/j.virol.2004.08.033]
27. Olinger CM, Weber B, Otegbayo JA, Ammerlaan W, van der Taelem-Brulé N, Muller CP. Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene. Med Microbiol Immunol 2007; 196: 247-252 [PMID: 17503077 DOI: 10.1007/s00430-007-0050-5]
28. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Férey MP, Ebel A, Dussaix E, Laperche S, Roque-Afonso AM. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J Clin Microbiol 2006; 44: 2321-2326 [PMID: 16825343 DOI: 10.1128/JCM.00121-06]
29. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 2001; 34: 1027-1034 [PMID: 11679975 DOI: 10.1053/jhep.2001.28708]
30. Yao QQ, Dong XL, Wang XC, Ge SX, Hu AQ, Liu HY, Wang YA, Yuan Q, Zheng YJ. Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination. Clin Vaccine Immunol 2013; 20: 269-275 [PMID: 23254298 DOI: 10.1128/CVI.00539-12]
31. Yong-Lin Y, Qiang F, Ming-Shun Z, Jie C, Gui-Ming M, Zu-Hu H, Xu-Bing C. Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Virol J 2012; 9: 82 [PMID: 22500577 DOI: 10.1186/1743-422X-9-82]
32. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, Levrero M, Raimondo G. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007; 45: 277-285 [PMID: 17256766 DOI: 10.1002/hep.21529]
33. Abdelnabi Z, Saleh N, Baraghithi S, Glebe D, Azzeh M. Subgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestine. PLoS One 2014; 9: e113821 [PMID: 25503289 DOI: 10.1371/journal.pone.0113821]
34. Darmawan E, Turyadi KE, Nursanty NK, Thedja MD, Muljono DH. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. J Med Virol 2015; 87: 199-207 [PMID: 25521058 DOI: 10.1002/jmv.24045]
35. Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti AR. Hepatitis B vaccination. Hum Vaccin Immunother 2015; 11: 53-57 [PMID: 25483515 DOI: 10.4161/hv.34306]
36. Thakur V, Kazim SN, Guptan RC, Hasnain SE, Bartholomeusz A, Malhotra V, Sarin SK. Transmission of G145R mutant of HBV to an unrelated contact. J Med Virol 2005; 76: 40-46 [PMID: 15778957 DOI: 10.1002/jmv.20321]
37. Norouzi M, Ghorashi S, Abedi F, Nejatizadeh A, Ataei B, Malekzadeh R, Alavian S, Judaki M, Ghamari S, Namazi A, Rahimnia R, Khedive A, Jazayeri S. Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran. Iran J Public Health 2012; 41: 104-111 [PMID: 23113154]
38. Komatsu H, Inui A, Sogo T, Konishi Y, Tateno A, Fujisawa T. Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers. BMC Res Notes 2012; 5: 22 [PMID: 22233650 DOI: 10.1186/1756-0500-5-22]
39. Mele A, Tancredi F, Romanò L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, Zanetti AR. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184: 905-908 [PMID: 11509998 DOI: 10.1086/323396]
40. Torresi J, Earnest-Silveira L, Deliyannis G, Edgtton K, Zhuang H, Locarnini SA, Fyfe J, Sozzi T, Jackson DC. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 2002; 293: 305-313 [PMID: 11886250 DOI: 10.1006/viro.2001.1246]
41. Zuckerman JN, Zuckerman AJ. Mutations of the surface protein of hepatitis B virus. Antiviral Res 2003; 60: 75-78 [PMID: 14638401 DOI: 10.1016/j.antiviral.2003.08.013]
42. Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, Wang C, Holmes SP, Babrzadeh F, Gharizadeh B, Hanczaruk B, Simen BB, Egholm M, Shafer RW. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis 2009; 199: 1275-1285 [PMID: 19301976 DOI: 10.1086/597808]
43. Araujo NM, Vianna CO, Moraes MT, Gomes SA. Expression of Hepatitis B virus surface antigen (HBsAg) from genotypes A, D and F and influence of amino acid variations related or not to genotypes on HBsAg detection. Braz J Infect Dis 2009; 13: 266-271 [PMID: 20231988 DOI: 10.1590/S1413-86702009000400005]
44. Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, Fraune M, Garcia A, Phillips RO. Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. J Clin Microbiol 2010; 48: 3223-3230 [PMID: 20631103 DOI: 10.1128/JCM.02231-09]
45. Dunford L, Carr MJ, Dean J, Nguyen LT, Ta Thi TH, Nguyen BT, Connell J, Coughlan S, Nguyen HT, Hall WW, Thi LA. A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLoS One 2012; 7: e39027 [PMID: 22720022 DOI: 10.1371/journal.pone.0039027]
46. Kuzin SN, Zabotina EE, Zabelin NN, Kudriavtseva EN, Samokhvalov EI, Borisova OV, Manina TA, Lisitsina EV, Kuzina LE, Malyshev NA, Lavrov VF. [Heterogeneity of hepatitis B virus and diagnostic potential of modern test systems for the detection of HBsAg]. Zh Mikrobiol Epidemiol Immunobiol 2012; (1): 68-75 [PMID: 22442974]
47. Lin YM, Jow GM, Mu SC, Chen BF. Naturally occurring hepatitis B virus B-cell and T-cell epitope mutants in hepatitis B vaccinated children. ScientificWorldJournal 2013; 2013: 571875 [PMID: 24379746 DOI: 10.1155/2013/571875]
48. Bian T, Yan H, Shen L, Wang F, Zhang S, Cao Y, Zhang S, Zhang Y, Bi S. Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China. J Virol 2013; 87: 12196-12206 [PMID: 24006443 DOI: 10.1128/JVI.02127-13]
49. Magiorkinis E, Paraskevis D, Pavlopoulou ID, Kantzanou M, Haida C, Hatzakis A, Boletis IN. Renal transplantation from hepatitis B surface antigen (HBsAg)-positive donors to HBsAg-negative recipients: a case of post-transplant fulminant hepatitis associated with an extensively mutated hepatitis B virus strain and review of the current literature. Transpl Infect Dis 2013; 15: 393-399 [PMID: 23773581 DOI: 10.1111/tid.12094]
50. Servant-Delmas A, Mercier-Darty M, Ly TD, Wind F, Alloui C, Sureau C, Laperche S. Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples. J Clin Virol 2012; 53: 338-345 [PMID: 22296790 DOI: 10.1016/j.jcv.2012.01.003]
51. Wu C, Shi H, Wang Y, Lu M, Xu Y, Chen X. A case of hepatitis B reactivation due to the hepatitis B virus escape mutant in a patient undergoing chemotherapy. Virol Sin 2012; 27: 369-372 [PMID: 23180290 DOI: 10.1007/s12250-012-3284-3]
52. Salpini R, Colagrossi L, Bellocchi MC, Surdo M, Becker C, Alteri C, Aragri M, Ricciardi A, Armenia D, Pollicita M, Di Santo F, Carioti L, Louzoun Y, Mastroianni CM, Lichtner M, Paoloni M, Esposito M, D'Amore C, Marrone A, Marignani M, Sarrecchia C, Sarmati L, Andreoni M, Angelico M, Verheyen J, Perno CF, Svicher V. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology 2015; 61: 823-833 [PMID: 25418031 DOI: 10.1002/hep.27604]
53. Bahramali G, Sadeghizadeh M, Amini-Bavil-Olyaee S, Alavian SM, Behzad-Behbahani A, Adeli A, Aghasadeghi MR, Amini S, Mahboudi F. Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients. World J Gastroenterol 2008; 14: 5448-5453 [PMID: 18803358 DOI: 10.3748/wjg.14.5448]
54. Chamni N, Louisirirotchanakul S, Oota S, Sakuldamrongpanish T, Saldanha J, Chongkolwatana V, Phikulsod S. Genetic characterization and genotyping of hepatitis B virus (HBV) isolates from donors with an occult HBV infection. Vox Sang 2014; 107: 324-332 [PMID: 25040474 DOI: 10.1111/vox.12178]
55. Youssef A, Yano Y, El-Sayed Zaki M, Utsumi T, Hayashi Y. Characteristics of hepatitis viruses among Egyptian children with acute hepatitis. Int J Oncol 2013; 42: 1459-1465 [PMID: 23404231 DOI: 10.3892/ijo.2013.1822]
56. Hamkar R, Aghakhani A, Soufian S, Banifazl M, Ghavami N, Nadri M, Sofian M, Ahmadi F, Razeghi E, Eslamifar A, Ramezani A. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection. Diagn Microbiol Infect Dis 2010; 66: 285-291 [PMID: 19903586 DOI: 10.1016/j.diagmicrobio.2009.10.006]
57. Datta S, Ghosh A, Dasgupta D, Ghosh A, Roychoudhury S, Roy G, Das S, Das K, Gupta S, Basu K, Basu A, Datta S, Chowdhury A, Banerjee S. Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma. PLoS One 2014; 9: e110012 [PMID: 25333524 DOI: 10.1371/journal.pone.0110012]
58. Yeung P, Wong DK, Lai CL, Fung J, Seto WK, Yuen MF. Profile of pre-S deletions in the natural history of chronic hepatitis B infection. J Med Virol 2010; 82: 1843-1849 [PMID: 20872710 DOI: 10.1002/jmv.21901]
59. Kim H, Lee SA, Kim DW, Lee SH, Kim BJ. Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C. PLoS One 2013; 8: e54486 [PMID: 23349904 DOI: 10.1371/journal.pone.0054486]
60. Zhang D, Dong P, Zhang K, Deng L, Bach C, Chen W, Li F, Protzer U, Ding H, Zeng C. Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment. BMC Microbiol 2012; 12: 307 [PMID: 23272650 DOI: 10.1186/1471-2180-12-307]
61. Zanetti AR, Tanzi E, Manzillo G, Maio G, Sbreglia C, Caporaso N, Thomas H, Zuckerman AJ. Hepatitis B variant in Europe. Lancet 1988; 2: 1132-1133 [PMID: 2460710 DOI: 10.1016/S0140-6736(88)90541-7]
62. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-329 [PMID: 1697396 DOI: 10.1016/0140-6736(90)91874-A]
63. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30: 1312-1317 [PMID: 10534356 DOI: 10.1002/hep.510300511]
64. François G, Kew M, Van Damme P, Mphahlele MJ, Meheus A. Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? Vaccine 2001; 19: 3799-3815 [PMID: 11427251]
65. Ireland JH, O'Donnell B, Basuni AA, Kean JD, Wallace LA, Lau GK, Carman WF. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 2000; 31: 1176-1182 [PMID: 10796895 DOI: 10.1053/he.2000.6407]
66. Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, Hahm KB, Cho SW. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 2001; 16: 359-362 [PMID: 11410701]
67. Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 2004; 50: 159-162 [PMID: 15074469]
68. Seddigh-Tonekaboni S, Lim WL, Young B, Hou JL, Waters J, Luo KX, Thomas HC, Karayiannis P. Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient. J Viral Hepat 2001; 8: 154-158 [PMID: 11264736 DOI: 10.1046/j.1365-2893.2001.00275.x]
69. Zuckerman AJ, Zuckerman JN. Molecular epidemiology of hepatitis B virus mutants. J Med Virol 1999; 58: 193-195 [PMID: 10447411]
70. Oon CJ, Chen WN, Goo KS, Goh KT. Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R. J Infect 2000; 41: 260-264 [PMID: 11120616 DOI: 10.1053/jinf.2000.0751]
71. Chakravarty R, Neogi M, Roychowdhury S, Panda CK. Presence of hepatitis B surface antigen mutant G145R DNA in the peripheral blood leukocytes of the family members of an asymptomatic carrier and evidence of its horizontal transmission. Virus Res 2002; 90: 133-141 [PMID: 12457969 DOI: 10.1016/S0168-1702(02)00147-8]
72. He C, Nomura F, Itoga S, Isobe K, Nakai T. Prevalence of vaccineinduced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees. J Gastroenterol Hepatol 2001; 16: 1373-1377 [PMID: 11851835 DOI: 10.1046/j.1440-1746.2001.02654.x]
73. Ngui SL, O'Connell S, Eglin RP, Heptonstall J, Teo CG. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis 1997; 176: 1360-1365 [PMID: 9359739 DOI: 10.1086/514133]
74. Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, Harrison TJ, Zuckerman AJ. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995; 13: 699-702 [PMID: 7483783]
75. Coleman PF, Chen YC, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999; 59: 19-24 [PMID: 10440803]
76. Zhang R, Wang L, Li J. Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen. Transfus Med 2010; 20: 322-328 [PMID: 20409073 DOI: 10.1111/j.1365-3148.2010.01007.x]
77. Sticchi L, Caligiuri P, Cacciani R, Alicino C, Bruzzone B. Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants. Hum Vaccin Immunother 2013; 9: 568-571 [PMID: 23296324 DOI: 10.4161/hv.23236]
78. Laoi BN, Crowley B. Molecular characterization of hepatitis B virus (HBV) isolates, including identification of a novel recombinant, in patients with acute HBV infection attending an Irish hospital. J Med Virol 2008; 80: 1554-1564 [PMID: 18649329 DOI: 10.1002/jmv.21273]
79. Luongo M, Critelli R, Grottola A, Gitto S, Bernabucci V, Bevini M, Vecchi C, Montagnani G, Villa E. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy. J Clin Virol 2015; 62: 89-91 [PMID: 25542480 DOI: 10.1016/j.jcv.2014.11.029]
80. Foy MC, Thio CL, Hwang HS, Saulynas M, Hamilton JP, Fine DM, Atta MG. False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States. Clin Vaccine Immunol 2012; 19: 820-822 [PMID: 22441395 DOI: 10.1128/CVI.05696-11]
81. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res 2007; 127: 164-176 [PMID: 17383765 DOI: 10.1016/j.virusres.2007.02.021]
82. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT, Lei HY, Shiau AL, Su IJ. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 2001; 33: 277-286 [PMID: 11124846 DOI: 10.1053/jhep.2001.21163]
83. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60 [PMID: 7612225 DOI: 10.1146/annurev.iy.13.040195.000333]
84. Wang HC, Huang W, Lai MD, Su IJ. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 2006; 97: 683-688 [PMID: 16863502 DOI: 10.1111/j.1349-7006.2006.00235.x]
85. Huy TT, Ushijima H, Win KM, Luengrojanakul P, Shrestha PK, Zhong ZH, Smirnov AV, Taltavull TC, Sata T, Abe K. High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol 2003; 41: 5449-5455 [PMID: 14662924 DOI: 10.1128/JCM.41.12.5449-5455.2003]
86. Sugauchi F, Ohno T, Orito E, Sakugawa H, Ichida T, Komatsu M, Kuramitsu T, Ueda R, Miyakawa Y, Mizokami M. Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol 2003; 70: 537-544 [PMID: 12794715 DOI: 10.1002/jmv.10428]
87. Raimondo G, Costantino L, Caccamo G, Pollicino T, Squadrito G, Cacciola I, Brancatelli S. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases. J Hepatol 2004; 40: 515-519 [PMID: 15123368 DOI: 10.1016/j.jhep.2003.11.025]
88. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 2006; 130: 1153-1168 [PMID: 16618410]
89. Lin CL, Liu CH, Chen W, Huang WL, Chen PJ, Lai MY, Chen DS, Kao JH. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 2007; 22: 1098-1103 [PMID: 17608857 DOI: 10.1111/j.1440-1746.2006.04515.x]
90. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, Rhee JC, Yoo BC. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 2007; 14: 161-168 [PMID: 17305881 DOI: 10.1111/j.1365-2893.2006.00784. x]
91. Gao ZY, Li T, Wang J, Du JM, Li YJ, Li J, Lu FM, Zhuang H. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol 2007; 42: 761-768 [PMID: 17876546 DOI: 10.1007/s00535-007-2085-1]
92. Mun HS, Lee SA, Jee Y, Kim H, Park JH, Song BC, Yoon JH, Kim YJ, Lee HS, Hyun JW, Hwang ES, Kook YH, Kim BJ. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J Med Virol 2008; 80: 1189-1194 [PMID: 18461612 DOI: 10.1002/jmv.21208]
93. Fang ZL, Sabin CA, Dong BQ, Wei SC, Chen QY, Fang KX, Yang JY, Huang J, Wang XY, Harrison TJ. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol 2008; 89: 2882-2890 [PMID: 18931087 DOI: 10.1099/vir.0.2008/002824-0]
94. Cao Z, Bai X, Guo X, Jin Y, Qian G, Tu H. High prevalence of hepatitis B virus pre-S mutation and its association with hepatocellular carcinoma in Qidong, China. Arch Virol 2008; 153: 1807-1812 [PMID: 18726170 DOI: 10.1007/s00705-008-0176-9]
95. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis 2008; 198: 1634-1642 [PMID: 18939932 DOI: 10.1086/592990]
96. Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. J Med Virol 2009; 81: 1531-1538 [PMID: 19623669 DOI: 10.1002/jmv.21577]
97. Yeung P, Wong DK, Lai CL, Fung J, Seto WK, Yuen MF. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. J Infect Dis 2011; 203: 646-654 [PMID: 21227916 DOI: 10.1093/infdis/jiq096]
98. Lee MH, Kim do Y, Kim JK, Chang HY, Kang SH, Ryu HJ, Ju HL, Kim SU, Lee JM, Park JY, Han KH, Chon CY, Ahn SH. Combination of preS deletions and A1762T/G1764A mutations in HBV subgenotype C2 increases the risk of developing HCC. Intervirology 2012; 55: 296-302 [PMID: 21865669 DOI: 10.1159/000329941]
99. Kao JH, Liu CJ, Jow GM, Chen PJ, Chen DS, Chen BF. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma. Liver Int 2012; 32: 1373-1381 [PMID: 22676233 DOI: 10.1111/j.1478-3231.2012.02826.x]
100. Sinn DH, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. Pre-s mutation is a significant risk factor for hepatocellular carcinoma development: a long-term retrospective cohort study. Dig Dis Sci 2013; 58: 751-758 [PMID: 23053886 DOI: 10.1007/s10620-012-2408-9]
101. Zhao ZM, Jin Y, Gan Y, Zhu Y, Chen TY, Wang JB, Sun Y, Cao ZG, Qian GS, Tu H. Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma. World J Gastroenterol 2014; 20: 13573-13581 [PMID: 25309088 DOI: 10.3748/wjg.v20.i37.13573]
102. Qu LS, Liu JX, Liu TT, Shen XZ, Chen TY, Ni ZP, Lu CH. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China. PLoS One 2014; 9: e98257 [PMID: 24849936 DOI: 10.1371/journal. pone.0098257]
103. Abe K, Thung SN, Wu HC, Tran TT, Le Hoang P, Truong KD, Inui A, Jang JJ, Su IJ. Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci 2009; 100: 2249-2254 [PMID: 19719772 DOI: 10.1111/j.1349-7006.2009.01309.x]
104. Huang HP, Hsu HY, Chen CL, Ni YH, Wang HY, Tsuei DJ, Chiang CL, Tsai YC, Chen HL, Chang MH. Pre-S2 deletions of hepatitis B virus and hepatocellular carcinoma in children. Pediatr Res 2010; 67: 90-94 [PMID: 19816238 DOI: 10.1203/PDR.0b013e3181c1b0b7]
105. Thongbai C, Sa-nguanmoo P, Kranokpiruk P, Poovorawan K, Poovorawan Y, Tangkijvanich P. Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand. Asian Pac J Cancer Prev 2013; 14: 3555-3559 [PMID: 23886144 DOI: 10.7314/APJCP.2013.14.6.3555]
106. Bläckberg J, Kidd-Ljunggren K. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma. J Med Virol 2003; 71: 18-23 [PMID: 12858404 DOI: 10.1002/jmv.10458]
107. Lee SA, Kim KJ, Kim DW, Kim BJ. Male-specific W4P/R mutation in the pre-S1 region of hepatitis B virus, increasing the risk of progression of liver diseases in chronic patients. J Clin Microbiol 2013; 51: 3928-3936 [PMID: 24025913 DOI: 10.1128/JCM.01505-13]
108. Sung JJ, Tsui SK, Tse CH, Ng EY, Leung KS, Lee KH, Mok TS, Bartholomeusz A, Au TC, Tsoi KK, Locarnini S, Chan HL. Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. J Virol 2008; 82: 3604-3611 [PMID: 18216102 DOI: 10.1128/JVI.01197-07]
109. Zhu Y, Jin Y, Guo X, Bai X, Chen T, Wang J, Qian G, Groopman JD, Gu J, Li J, Tu H. Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2010; 19: 2623-2630 [PMID: 20699378 DOI: 10.1158/1055-9965.EPI-10-0469]
110. Hung CH, Chen CH, Lee CM, Hu TH, Lu SN, Wang JH, Huang CM. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection. Intervirology 2013; 56: 316-324 [PMID: 23838434 DOI: 10.1159/000350738]